The Cytokine Network of Acute HIV Infection: A Promising Target for Vaccines and Therapy to Reduce Viral Set-Point?

English version České info

Cytokines play a central role in the pathogenesis of many diseases, including HIV infection. However, the role of the cytokine network in early HIV infection is only now starting to be elucidated. A number of studies conducted in recent years have indicated that cytokines of the acute/early stages of HIV and SIV infection can impact viral set-point months later, and this is of critical importance since viral set-point during chronic HIV infection affects virus transmission and disease progression. This raises the question whether modulating the cytokine environment during acute/early HIV infection can be a target for novel approaches to develop a vaccine and therapeutics. In this review we focus on the kinetics and function of cytokines during acute HIV and SIV infection and how these may impact viral set-point. We also discuss unresolved questions that are essential for our understanding of the role of acute infection cytokines in HIV infection and that, if answered, may suggest novel therapeutic and vaccine strategies to control the worldwide HIV pandemic.

Vyšlo v časopise: The Cytokine Network of Acute HIV Infection: A Promising Target for Vaccines and Therapy to Reduce Viral Set-Point?. PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002055
Kategorie: Review
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002055

Souhrn

Zdroje

1. WeissmanDBarkerTDFauciAS 1996 The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation. J Exp Med 183 687 692

2. BosingerSEHosiawaKACameronMJPersadDRanL 2004 Gene expression profiling of host response in models of acute HIV infection. J Immunol 173 6858 6863

3. McMichaelAJBorrowPTomarasGDGoonetillekeNHaynesBF 2010 The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10 11 23

4. FolksTRoweTVillingerFParekhBMayneA 1997 Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques. J Med Primatol 26 181 189

5. SchwiebertRFultzPN 1994 Immune activation and viral burden in acute disease induced by simian immunodeficiency virus SIVsmmPBj14: correlation between in vitro and in vivo events. J Virol 68 5538 5547

6. GarberDASilvestriGBarryAPFedanovAKozyrN 2004 Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication. J Clin Invest 113 836 845

7. StapransSIBarryAPSilvestriGSafritJTKozyrN 2004 Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein. Proc Natl Acad Sci U S A 101 13026 13031

8. AnsariAAMayneAESundstromJBBostikPGrimmB 2002 Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques. J Virol 76 1731 1743

9. GiavedoniLDVelasquilloMCParodiLMHubbardGBHodaraVL 2002 Expression of IL-18 by SIV does not modify the outcome of the antiviral immune response. Virology 303 327 337

10. MuellerYMDoDHAltorkSRArtlettCMGracelyEJ 2008 IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J Immunol 180 350 360

11. SawaiETHamzaMSYeMShawKELuciwPA 2000 Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef. J Virol 74 2038 2045

12. SalvatoMSYinCCYagitaHMaedaTOkumuraK 2007 Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. Clin Dev Immunol 93462 2007

13. BiglinoASiniccoAFornoBPollonoAMSciandraM 1996 Serum cytokine profiles in acute primary HIV-1 infection and in infectious mononucleosis. Clin Immunol Immunopathol 78 61 69

14. GraziosiCGanttKRVaccarezzaMDemarestJFDaucherM 1996 Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A 93 4386 4391

15. StaceyARNorrisPJQinLHaygreenEATaylorE 2009 Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 83 3719 3733

16. NilssonJKinloch-de-LoesSGranathASonnerborgAGohLE 2007 Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection. AIDS 21 565 574

17. PoliGKinterALFauciAS 1994 Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A 91 108 112

18. AbelKRockeDMChohanBFrittsLMillerCJ 2005 Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J Virol 79 12164 12172

19. BosingerSELiQGordonSNKlattNRDuanL 2009 Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest 119 3556 3572

20. JacquelinBMayauVTargatBLiovatASKunkelD 2009 Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119 3544 3555

21. LedererSFavreDWaltersKAProllSKanwarB 2009 Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization. PLoS Pathog 5 e1000296 doi:10.1371/journal.ppat.1000296

22. LiQEstesJDSchlievertPMDuanLBrosnahanAJ 2009 Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 1034 1038

23. NaickerDDWernerLKormuthEPassmoreJAMlisanaK 2009 Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 200 448 452

24. BenvenisteOVaslinBLe GrandRCheretAMatheuxF 1996 Comparative interleukin (IL-2)/interferon IFN-gamma and IL-4/IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SICmac251 virus. Proc Natl Acad Sci U S A 93 3658 3663

25. ZouWLacknerAASimonMDurand-GasselinIGalanaudP 1997 Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J Virol 71 1227 1236

26. CheretALe GrandRCaufourPDereuddre-BosquetNMatheuxF 1996 Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of macaques. AIDS Res Hum Retroviruses 12 1263 1272

27. CheretALe GrandRCaufourPNeildezOMatheuxF 1999 RANTES, IFN-gamma, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques. Virology 255 285 293

28. KhatissianEChakrabartiLHurtrelB 1996 Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection. Res Virol 147 181 189

29. GiavedoniLDVelasquilloMCParodiLMHubbardGBHodaraVL 2000 Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol 74 1648 1657

30. HaaseAT 2010 Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464 217 223

31. MillerCJLiQAbelKKimEYMaZM 2005 Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79 9217 9227

32. EberlyMDKaderMHassanWRogersKAZhouJ 2009 Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J Immunol 182 1439 1448

33. EstesJDLiQReynoldsMRWietgrefeSDuanL 2006 Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193 703 712

34. KornfeldCPloquinMJPandreaIFayeAOnangaR 2005 Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115 1082 1091

35. CuaDJTatoCM 2010 Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10 479 489

36. FavreDLedererSKanwarBMaZMProllS 2009 Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 5 e1000295 doi:10.1371/journal.ppat.1000295

37. RaffatelluMSantosRLVerhoevenDEGeorgeMDWilsonRP 2008 Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 421 428

38. BrenchleyJMPaiardiniMKnoxKSAsherAICervasiB 2008 Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112 2826 2835

39. Campillo-GimenezLCumontMCFayMKaredHMonceauxV 2010 AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. J Immunol 184 984 992

40. Furuzawa-CarballedaJVargas-RojasMICabralAR 2007 Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6 169 175

41. ColonnaMTrinchieriGLiuYJ 2004 Plasmacytoid dendritic cells in immunity. Nat Immunol 5 1219 1226

42. HsiehCSMacatoniaSETrippCSWolfSFO'GarraA 2008 Pillars article: development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. 1993. Science 260(5107): 547-549. J Immunol 181 4437 4439

43. MacatoniaSEHoskenNALittonMVieiraPHsiehCS 1995 Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 154 5071 5079

44. CarsonWERossMEBaiocchiRAMarienMJBoianiN 1995 Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 96 2578 2582

45. GrabsteinKHEisenmanJShanebeckKRauchCSrinivasanS 1994 Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264 965 968

46. JonuleitHWiedemannKMullerGDegwertJHoppeU 1997 Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells. J Immunol 158 2610 2615

47. GoonetillekeNLiuMKSalazar-GonzalezJFFerrariGGiorgiE 2009 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206 1253 1272

48. VallabhapurapuSKarinM 2009 Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27 693 733

49. AlcamiJLain de LeraTFolgueiraLPedrazaMAJacqueJM 1995 Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 14 1552 1560

50. ChenBKFeinbergMBBaltimoreD 1997 The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J Virol 71 5495 5504

51. OsbornLKunkelSNabelGJ 1989 Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 86 2336 2340

52. MuellerYMPetrovasCBojczukPMDimitriouIDBeerB 2005 Interleukin-15 increases effector memory CD8+ t cells and NK Cells in simian immunodeficiency virus-infected macaques. J Virol 79 4877 4885

53. MuellerYMBojczukPMHalsteadESKimAHWitekJ 2003 IL-15 enhances survival and function of HIV-specific CD8+ T cells. Blood 101 1024 1029

54. PetrovasCMuellerYMDimitriouIDBojczukPMMounzerKC 2004 HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J Immunol 172 4444 4453

55. RobertsLPassmoreJAWilliamsonCLittleFBebellLM 2010 Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 24 819 831

56. HarriganPRWhaleyMMontanerJS 1999 Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy. AIDS 13 F59 62

57. HatanoHVogelSYoderCMetcalfJADewarR 2000 Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS 14 1357 1363

58. NeumannAUTubianaRCalvezVRobertCLiTS 1999 HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group. AIDS 13 677 683

59. KlattNRVillingerFBostikPGordonSNPereiraL 2008 Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys. J Clin Invest 118 2039 2049

60. de WolfFSpijkermanISchellekensPTLangendamMKuikenC 1997 AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion. AIDS 11 1799 1806

61. MellorsJWRinaldoCRJrGuptaPWhiteRMToddJA 1996 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 1167 1170

62. GarciaPMKalishLAPittJMinkoffHQuinnTC 1999 Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341 394 402

63. MayauxMJDussaixEIsopetJRekacewiczCMandelbrotL 1997 Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 175 172 175

64. QuinnTCWawerMJSewankamboNSerwaddaDLiC 2000 Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342 921 929

65. SperlingRSShapiroDECoombsRWToddJAHermanSA 1996 Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 335 1621 1629

66. ShinHDWinklerCStephensJCBreamJYoungH 2000 Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci U S A 97 14467 14472

67. OkoyeAParkHRohankhedkarMCoyne-JohnsonLLumR 2009 Profound CD4+/CCR5+ T cell expansion is induced by CD8+ lymphocyte depletion but does not account for accelerated SIV pathogenesis. J Exp Med 206 1575 1588

68. VillingerFBucurSChikkalaNFBrarSSBostikP 2000 In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS. AIDS Res Hum Retroviruses 16 751 763

69. WatanabeNSypekJPMittlerSReimannKAFlores-VillanuevaP 1998 Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys. AIDS Res Hum Retroviruses 14 393 399

70. WangYAbelKLantzKKriegAMMcChesneyMB 2005 The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J Virol 79 14355 14370

71. EstaquierJIdziorekTZouWEmilieDFarberCM 1995 T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)- mediated apoptosis of CD4+ T cells from human immunodeficiency virus- infected persons. J Exp Med 182 1759 1767

72. PooniaBSalvatoMSYagitaHMaedaTOkumuraK 2009 Treatment with anti-FasL antibody preserves memory lymphocytes and virus-specific cellular immunity in macaques challenged with simian immunodeficiency virus. Blood 114 1196 1204

73. BosaniMArdizzoneSPorroGB 2009 Biologic targeting in the treatment of inflammatory bowel diseases. Biologics 3 77 97

74. FeldmanMTaylorPPaleologEBrennanFMMainiRN 1998 Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Transplant Proc 30 4126 4127

75. FeldmannMMainiSR 2008 Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223 7 19

76. HansenSGVievilleCWhizinNCoyne-JohnsonLSiessDC 2009 Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15 293 299

77. SilvaDGCooperPDPetrovskyN 2004 Inulin-derived adjuvants efficiently promote both Th1 and Th2 immune responses. Immunol Cell Biol 82 611 616

78. DuthieMSWindishHPFoxCBReedSG 2011 Use of defined TLR ligands as adjuvants within human vaccines. Immunol Rev 239 178 196

79. BaldwinSLShaverdianNGotoYDuthieMSRamanVS 2009 Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion. Vaccine 27 5956 5963

80. Mata-HaroVCekicCMartinMChiltonPMCasellaCR 2007 The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316 1628 1632

81. KutzlerMARobinsonTMChattergoonMAChooDKChooAY 2005 Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help. J Immunol 175 112 123

82. BoyerJDRobinsonTMKutzlerMAVansantGHokeyDA 2007 Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. Proc Natl Acad Sci U S A 104 18648 18653

83. DubieRAMaksaereekulSShacklettBLLemongelloDColeKS 2009 Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251. Virology 386 109 121